2024

1. A multilayer network analysis of Alzheimer's disease pathogenesis: Roles for p-tau, synaptic peptides, and physical activity

   Alzheimer's and Dementia

2. Alcohol Triggers the Accumulation of Oxidatively Damaged Proteins in Neuronal Cells and Tissues

   Antioxidants, Vol. 13, Núm. 5

3. Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus

   Lupus Science and Medicine, Vol. 11, Núm. 1

4. Anticoagulant and non-anticoagulant therapy in thrombotic antiphospholipid syndrome: old drugs and new treatment targets

   Rheumatology (United Kingdom), Vol. 63, Núm. SI, pp. SI96-SI106

5. Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus

   Expert Review of Clinical Immunology, Vol. 20, Núm. 4, pp. 359-373

6. Clinical Predictors of Mood Disorders and Prevalence of Neuropsychiatric Symptoms in Patients with Systemic Lupus Erythematosus

   Journal of Clinical Medicine, Vol. 13, Núm. 18

7. Conformation- and activation-based BRET sensors differentially report on GPCR-G protein coupling

   Science signaling, Vol. 17, Núm. 841, pp. eadi4747

8. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects

   Translational Psychiatry, Vol. 14, Núm. 1

9. Effects of cannabidiol in post-stroke mood disorders in neonatal rats

   Pediatric Research, Vol. 95, Núm. 7, pp. 1783-1790

10. Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis

    Therapeutic Advances in Psychopharmacology, Vol. 14

11. Elucidating the mechanisms and efficacy of antimalarial drugs in systemic lupus erythematosus

    Expert Opinion on Pharmacotherapy

12. Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

    European Neuropsychopharmacology, Vol. 85, pp. 66-77

13. Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands

    Bioorganic Chemistry, Vol. 142

14. G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits

    Nature communications, Vol. 15, Núm. 1, pp. 4307

15. Gender sensitivity of the COVID-19 mental health research in Europe: a scoping review

    International Journal for Equity in Health, Vol. 23, Núm. 1

16. High number of mitochondrial DNA alterations in postmortem brain tissue of patients with schizophrenia compared to healthy controls

    Psychiatry Research, Vol. 337

17. Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?

    Autoimmunity Reviews, Vol. 23, Núm. 1

18. Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain

    British Journal of Pharmacology

19. Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort

    Arthritis Care and Research, Vol. 76, Núm. 8, pp. 1132-1138

20. NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia

    Brain Structure and Function, Vol. 229, Núm. 5, pp. 1299-1315